Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Safety of non-therapeutic levetiracetam ingestions--a poison center based study.

Bodmer M, Monte AA, Kokko J, Yin S.

Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):366-9. doi: 10.1002/pds.2113. Epub 2011 Feb 17.

PMID:
21328633
2.

An 11-year review of levetiracetam ingestions in children less than 6 years of age.

Lewis JC, Albertson TE, Walsh MJ.

Clin Toxicol (Phila). 2014 Nov;52(9):964-8. doi: 10.3109/15563650.2014.965828. Epub 2014 Oct 6. Review.

PMID:
25283254
3.

Overdose with levetiracetam: a case report and review of the literature.

Larkin TM, Cohen-Oram AN, Catalano G, Catalano MC.

J Clin Pharm Ther. 2013 Feb;38(1):68-70. doi: 10.1111/j.1365-2710.2012.01361.x. Epub 2012 Jun 21. Review.

PMID:
22725831
4.

Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.

Scharman EJ, Erdman AR, Cobaugh DJ, Olson KR, Woolf AD, Caravati EM, Chyka PA, Booze LL, Manoguerra AS, Nelson LS, Christianson G, Troutman WG; American Association of Poison Control Centers..

Clin Toxicol (Phila). 2007 Oct-Nov;45(7):737-52.

PMID:
18058301
5.

The safety of levetiracetam.

Sirsi D, Safdieh JE.

Expert Opin Drug Saf. 2007 May;6(3):241-50. Review.

PMID:
17480174
6.

1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Litovitz TL, Holm KC, Clancy C, Schmitz BF, Clark LR, Oderda GM.

Am J Emerg Med. 1993 Sep;11(5):494-555. Review. No abstract available.

PMID:
8103331
7.

Safety profile of levetiracetam.

Harden C.

Epilepsia. 2001;42 Suppl 4:36-9. Review.

8.

Adverse events associated with dietary supplements: an observational study.

Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A, Sprague BM, Ko R, Everson G, Nelson LS, Dodd-Butera T, Bartlett WD, Landzberg BR.

Lancet. 2003 Jan 11;361(9352):101-6. Review.

PMID:
12531576

Supplemental Content

Support Center